Kenneth Gollob

Kenneth Gollob is an accomplished expert in immuno-oncology and translational research, currently serving as the Director of the Center for Research in Immuno-oncology at Hospital Albert Einstein. Gollob also holds the position of Editor-in-Chief for the journal Einstein and has a significant background in life-saving diagnostics as the founder of BRISA Biotech. Previous roles include leadership positions at A.C.Camargo Cancer Center and Instituto Mario Penna, along with editorial responsibilities at Springer Nature. Gollob's research focuses on multiomics approaches for cancer therapeutics and biomarker discovery, complemented by extensive academic experience in immunology at various institutions, including Stanford University and the Universidade Federal de Minas Gerais. Gollob earned a PhD in Microbiology and Immunology from the University of Colorado School of Medicine and a B.S. in Molecular, Cellular and Developmental Biology from the University of Colorado Boulder.